Semliki Forest virus-based vaccines: Persistence, distribution and pathological analysis in two animal systems

Vaccine

Volumn 19, Issue 15-16, 2001, Pages 1978-1988

  Morris Downes, Margaret M ^a   Phenix, Kerry V ^b   Smyth, Joan ^b   Sheahan, Brian J ^c   Lileqvist, Sissela ^d   Mooney, Dorothy A ^a   Liljeström, Peter ^d,e   Todd, Daniel ^b   Atkins, Gregory J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Biosafety; Recombinant vaccines; Semliki Forest virus

Indexed keywords

DNA VACCINE; PLASMID DNA; RECOMBINANT RNA; RECOMBINANT VACCINE; VIRUS RNA; VIRUS VACCINE;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; FETUS; HISTOPATHOLOGY; INJECTION SITE; LYMPHOID ORGAN; MOUSE; MUSCLE INJURY; NONHUMAN; PRIORITY JOURNAL; SAFETY; SEMLIKI FOREST ALPHAVIRUS; TISSUE DISTRIBUTION; VACCINATION;

ANIMALS; BASE SEQUENCE; CHICKENS; DNA PRIMERS; FEMALE; GREEN FLUORESCENT PROTEINS; INJECTIONS, INTRAMUSCULAR; LUMINESCENT PROTEINS; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAFETY; SEMLIKI FOREST VIRUS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; VACCINES, DNA; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0035961505     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00428-X     Document Type: Article

References (41)

1. Potential DNA vaccine integration into host cell genome
2. Plasmid DNA malaria vaccine: The potential for genomic integration after intramuscular injection
3. Do DNA vaccines induce autoimmune disease?
4. Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA
5. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle
6. Plasmid DNA malaria vaccine: Tissue distribution and safety studies in mice and rabbits
7. Induction of neonatal tolerance by plasmid DNA vaccination of mice
8. Sindbis virus: An efficient, broad host range vector for gene expression in animal cells
9. A new generation of animal cell expression vectors based on Semliki Forest virus replicon
10. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus - Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo
11. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine
12. Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells
13. Semliki Forest virus expression system: Production of conditionally infectious recombinant particles
14. Two-helper RNA system for production of recombinant Semliki forest virus particles
15. Enhancing immune responses using suicidal DNA vaccines
16. Self-replicating Semliki Forest virus RNA as recombinant vaccine
17. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus
18. Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type I envelope protein and challenge with a high dose of SHIV-4 virus
19. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice
20. Protection against lethal SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by gp120 subunit vaccine
21. Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge
22. Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles
23. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice
24. Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage
25. Long-term effects of Semliki Forest virus infection in the mouse central nervous system
26. Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection
27. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10
28. Distribution of retroviral vectors and vector producer cells using two routes of administration in rats
29. Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice
30. Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P] DNA following intravenous administration of DNA/cationic lipid complexes in mice: Use of a novel radionuclide approach
31. Inhibition of PM-2 DNA degradation by a human serum protein
32. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells
33. Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles
34. Protection against homologous influenza challenge by genetic immunization with SFV-RNA encoding Flu-HA
35. DNA immunization against herpes simplex virus: Enhanced efficacy using a Sindbis virus-based vector
36. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing hantavirus structural genes in hamsters
37. The Semliki Forest virus vector induces p53-independent apoptosis
38. Semliki Forest virus-based DNA expression vector - Transient protein production followed by cell death
39. Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and non-human primates
40. High expression of naked plasmid DNA in muscles of young rodents
41. Cancer therapy using a self-replicating RNA vaccine